May 6th 2024
Analysis reveals rising hospitalization rates among pregnant women with hepatitis C virus (HCV) and age as a critical factor influencing maternal and fetal health outcomes.
Exploring the Link Between Steatosis Progression and HIV & HCV Infection
May 30th 2017Not much is known about how HIV mono-infection contributes to the development of hepatic steatosis, due to how difficult diagnosis of this condition used to be. Now, with the developement of noninvasive tools, it is easier to diagnose steatosis.
Read More
Statins Protect Patients with HBV/HCV-Related Liver Cirrhosis from Developing Decompensation
May 2nd 2017A study using the Taiwan National Health Insurance research database investigated the efficacy of statin use on preventing the development of liver decompensation in patients with different cirrhosis etiologies.
Read More
WHO Reports Global Burden of Viral Hepatitis Is Increasing
April 22nd 2017The World Health Organization just published the first ever Global Hepatitis Report, which notes that the viral hepatitis mortality rate is increasing worldwide, while deaths caused by HIV and tuberculosis continues to drop.
Read More
Examining HCV Burden in EU and Measures to Eradicate it by 2030
April 17th 2017Researchers from the Center for Disease Analysis investigated the incidence of hepatitis C in the European Union (EU) and examined the measures that would be needed to achieve the World Health Organization’s ultimate goal of eradicating the disease by 2030.
Read More
Doctors Without Borders Among 30 Groups to Challenge HCV Drug Patent in Europe
April 13th 2017Doctors Without Borders and humanitarian groups across Europe are coordinating their opposition to Gilead Sciences Inc’s patent for hepatitis C treatment sofosbuvir, the basis for the biopharmaceutical giant’s Sovaldi, Harvoni, and Epclusa drugs.
Read More
Hepatitis C and the Dwindling of Research Funding
March 14th 2017Hepatitis C virus is the world’s most prevalent blood-borne viral infection for which a vaccine does not exist. To eliminate HCV infection on a global scale, experts argue that vaccine development needs to become a public health priority.
Read More
HCV Testing Remains Low Among High-Risk Population
March 11th 2017When the US Preventive Services Task Force (USPSTF) recommended that all baby boomers undergo a one-time hepatitis C screening in 2013, testing prevalence increased. However, the rate is still lower than officials would like to see.
Read More